Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 80

Sort by

Sort Order Select

Journal Articles

Interferon in Polycythemia Vera (PV) Yields Improved Myelofibrosis-Free and Overall Survival

Ghaith Abu Zeinah, MD, Spencer Krichevsky, BS, Diana Jaber, BA, Niamh Savage, BA, Claudia Sosner, BA, Gabriela Hoberman, BA, Ellen K. Ritchie, MD, Andrew I. Schafer, MD, Joseph Scandura, MD PhD, Richard T. Silver, MD

Blood (2019) 134 (Supplement_1): 2942.

https://doi.org/10.1182/blood-2019-130265

Published: 2019

Journal Articles

Prognostic Effects of Pretreatment Statuses at Diagnosis in Patients with Chronic Myeloid Leukemia: Results of the New Target Observational Study 1

Takaaki ONO, MD PhD, Naoto Takahashi, MD PhD, Masahiro Kizaki, MD, Tatsuya Kawaguchi, MD, Ritsuro Suzuki, MD PhD, Kazuhito Yamamoto, Kazunori Ohnishi, MD, Tomoki Naoe, MD PhD, Itaru Matsumura, MD PhD

Blood (2019) 134 (Supplement_1): 4149.

https://doi.org/10.1182/blood-2019-122092

Published: 2019

Journal Articles

The 'Real World' Uptake and Prognostic Impact of GELF in Newly Diagnosed Follicular Lymphoma: An Australasian Alliance Initiative

Allison Barraclough, Edward Yoo, Chan Y. Cheah, Dipti Talaulikar, Bianca Nguyen, Michelle Turner, Fatima Tahir, Jing Huang, Colm Keane, MD, Mitchel Lincoln, Tara Cochrane, Anna M. Johnston, Michael Dickinson, MBBS,FRACP,FRCPA, Stephen Opat, Zoe McQuilten, Erica M. Wood, Gayathri St George, Cameron Wellard, Eliza A Hawkes

Blood (2019) 134 (Supplement_1): 3986.

https://doi.org/10.1182/blood-2019-129294

Published: 2019

Journal Articles

A Phase I-II Study of Ruxolitinib (INCB18424) for Patients with Chronic Myeloid Leukemia with Minimal Residual Disease While on Therapy with Imatinib

Veronica A Guerra, MD, Hagop M. Kantarjian, MD, Gautam M. Borthakur, MD, Srdan Verstovsek, MD PhD, Allison Pike, RN, Farhad Ravandi, MD, Elias Jabbour, MD, Jorge E. Cortes, MD

Blood (2019) 134 (Supplement_1): 5906.

https://doi.org/10.1182/blood-2019-127272

Published: 2019

Journal Articles

Management and Outcome of 11 Pregnancies in Women with Polycythemia Vera

Elena Maria Elli, MD, Rossella Calori, MD, Ida Carmosino, Massimo Breccia, MD, Elisa Diral, MD, Carlo Gambacorti-Passerini, MD, Ambra Di Veroli, MD, Roberto Latagliata

Blood (2018) 132 (Supplement 1): 5471.

https://doi.org/10.1182/blood-2018-99-119663

Published: 2018

Journal Articles

Survival Among Minority Populations with Chronic Myeloid Leukemia: A Surveillance Epidemiology and End Results Database Analysis

Owhofasa Agbedia, MD, Julius Ngwa, PhD, Deepika S. Darbari, MD, Patricia Oneal, MD

Blood (2018) 132 (Supplement 1): 3546.

https://doi.org/10.1182/blood-2018-99-119923

Published: 2018

Journal Articles

The Role of Maintenance Therapy in Patients with Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

Alon Rozental, MD, Anat Gafter-Gvilli, MD, Liat Vidal-Fisher, MD MSc, Pia Raanani, Ronit Gurion, MD

Blood (2017) 130 (Supplement 1): 4117.

https://doi.org/10.1182/blood.V130.Suppl_1.4117.4117

Published: 2017

Journal Articles

Management of Chronic Myeloid Leukemia (CML) during Pregnancy Among Patients (pts) Treated with a Tyrosine Kinase Inhibitor (TKI): A Single-Center Experience

Rita Assi, MD, Hagop M. Kantarjian, MD, Michael J. Keating, MD, Naveen Pemmaraju, MD, Srdan Verstovsek, MD PhD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MBBS, Gautam Borthakur, MD, Jenny Dahl, MS, PA-C, Elias J. Jabbour, MD, Jorge E. Cortes, MD

Blood (2017) 130 (Supplement 1): 2881.

https://doi.org/10.1182/blood.V130.Suppl_1.2881.2881

Published: 2017

Journal Articles

Characteristics of 809 Patients with Essential Thrombocythemia in Real-World Clinical Practice: A Chart Review Study in the United States

Jingbo Yu, PhD, Philomena Colucci, DO, MS, Dilan Chamikara Paranagama, PhD, Smitha Sivaraman, PhD, Pavel Atanasov, Becky Hanna, Jackson Tang, Shreekant V. Parasuraman, BPharm, PhD

Blood (2017) 130 (Supplement 1): 1636.

https://doi.org/10.1182/blood.V130.Suppl_1.1636.1636

Published: 2017

Journal Articles

Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splanchnic or Cerebral Venous Thrombosis

Serena Rupoli, MD, Lucia Canafoglia, MD, Gianluca Svegliati Baroni, MD, Michele Gironella, MD, Giorgia Micucci, MD, Irene Federici, BSc, Massimo Offidani, Gaia Goteri, MD, Alessandro Fiorentini, MD, Alessandra Riva, MD, Lidia Da Lio, MD, Leandro Provinciali, MD, Anna Rita Scortechini, MD, Elisa Honorati, MD, Pietro Leoni, Prof

Blood (2016) 128 (22): 4257.

https://doi.org/10.1182/blood.V128.22.4257.4257

Published: 2016

Journal Articles

SD-101, a Novel Class C CpG-Oligodeoxynucleotide (ODN) Toll-like Receptor 9 (TLR9) Agonist, Given with Low Dose Radiation for Untreated Low Grade B-Cell Lymphoma: Interim Results of a Phase 1/2 Trial

Ronald Levy, MD, Patrick M. Reagan, MD, Jonathan W. Friedberg, MD, Nancy L Bartlett, MD, Leo I. Gordon, MD, Abraham Leung, MD, Joanna Peterkin, MD MS, Biao Xing, Robert Coffman, PhD, Robert Janssen, MD, Albert Candia, PhD, Michael Khodadoust, MD PhD, Matthew J. Frank, MD PhD, Steven R Long, MD, Debra K Czerwinski, Michael Chu, MD

Blood (2016) 128 (22): 2974.

https://doi.org/10.1182/blood.V128.22.2974.2974

Published: 2016

Journal Articles

Maintenance Therapy for Patients with Mantle Cell Lymphoma (MCL) - a Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs)

Liat Vidal, MD MSc, Anat Gafter-Gvili, MD, Martin H. Dreyling, Michael Unterhalt, PhD, Pia Raanani, MD, Michele Ghielmini, MD professor, Ronit Gurion

Blood (2016) 128 (22): 1802.

https://doi.org/10.1182/blood.V128.22.1802.1802

Published: 2016

Journal Articles

Bridging to Second Allogeneic Peripheral Blood Stem Cell Transplantation with Nelarabine in a Patient with Multiply Relapsed/Refractory T-Cell ALL

Jacqueline Baptista, RN, APN, Eris Tollkuci, PharmD, Sunita Nathan, MD, John J. Maciejewski, MD PhD, Melissa L. Larson, MD, Gorgun Akpek, MD MHS

Blood (2016) 128 (22): 5200.

https://doi.org/10.1182/blood.V128.22.5200.5200

Published: 2016

Journal Articles

The Effect of Initial Molecular Profile on Response to Recombinant Interferon Alpha (rIFNα) Treatment in Early Myelofibrosis

Richard T. Silver, Ariella Barel, Elena Lascu, BA,MA, Ellen K. Ritchie, MD, Gail J. Roboz, MD, Paul Christos, Attilio Orazi, MD, Duane C Hassane, PhD, Wayne Tam, MD PhD, Nicholas C.P. Cross, PhD

Blood (2016) 128 (22): 944.

https://doi.org/10.1182/blood.V128.22.944.944

Published: 2016

Journal Articles

Hasford Score Is Correlated with 18 Month Molecular Response for Chronic Myeloid Leukemia Patients Treated with Second Generation Tyrosine Kinase Inhibitors and It May be Useful to Differentiate Low and Intermediate Risk Patients: A Single Institution Experience

Jaroslaw Dybko, Olga Haus, MD, Bozena Jazwiec, Tomasz Lonc, Mateusz Sawicki, Kazimierz Kuliczkowski

Blood (2015) 126 (23): 5163.

https://doi.org/10.1182/blood.V126.23.5163.5163

Published: 2015

Journal Articles

Retrospective Analysis of Minimal Residual Disease-Guided Preemptive Treatment in Patients with AML and MDS - the SAL Study Group Experience

Ekaterina Bulycheva, MD, Jiri Mayer, Prof., MD, William Hermann Krüger, MD PhD, Peter Dreger, MD, Anna Mies, Zuzana Sustkova, MD, Zdenek Racil, MD, Jirina Prochazkova, MD, Eva Walter, MD, Carsten Hirt, Mark Ringhoffer, MD, Wolfgang E Berdel, MD, Hubert Serve, MD, Christoph Rollig, Katja Sockel, MD, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Christian Thiede, MD PhD, Uwe Platzbecker, MD

Blood (2015) 126 (23): 3817.

https://doi.org/10.1182/blood.V126.23.3817.3817

Published: 2015

Journal Articles

A Phase II Study of Panobinostat with Lenalidomide and Weekly Dexamethasone in Myeloma

Blood (2015) 126 (23): 4226.

https://doi.org/10.1182/blood.V126.23.4226.4226

Published: 2015

Journal Articles

Rituximab Maintenance (MR) for Patients with Mantle Cell Lymphoma (MCL) – a Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs)

Liat Vidal, MDMSc, Anat Gafter-Gvili, MD, Martin Dreyling, Michele Ghielmini, MD, Michael Unterhalt, MD, Pia Raanani, MD, Ofer Shpilberg, MD, Ron Ram, MD, Ronit Gurion, MD

Blood (2014) 124 (21): 4466.

https://doi.org/10.1182/blood.V124.21.4466.4466

Published: 2014

Journal Articles

Cladribine for the Management of Erdheim-Chester Histiocytosis in Adults

Harsh Patel, Cary Kraft, Gary J. Schiller, MD FACP

Blood (2014) 124 (21): 5551.

https://doi.org/10.1182/blood.V124.21.5551.5551

Published: 2014

Journal Articles

Pregnancy Management and Outcomes In Women With Myeloproliferative Disease

Eugenia S. Polushkina, Roman G. Shmakov, Maria A. Vinogradova, Manana A. Sokolova, Nina D. Khoroshko

Blood (2013) 122 (21): 1711.

https://doi.org/10.1182/blood.V122.21.1711.1711

Published: 2013

NARROW

Interferon in Polycythemia Vera (PV) Yields Improved Myelofibrosis-Free and Overall Survival

Prognostic Effects of Pretreatment Statuses at Diagnosis in Patients with Chronic Myeloid Leukemia: Results of the New Target Observational Study 1

The 'Real World' Uptake and Prognostic Impact of GELF in Newly Diagnosed Follicular Lymphoma: An Australasian Alliance Initiative

A Phase I-II Study of Ruxolitinib (INCB18424) for Patients with Chronic Myeloid Leukemia with Minimal Residual Disease While on Therapy with Imatinib

Management and Outcome of 11 Pregnancies in Women with Polycythemia Vera

Survival Among Minority Populations with Chronic Myeloid Leukemia: A Surveillance Epidemiology and End Results Database Analysis

The Role of Maintenance Therapy in Patients with Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

Management of Chronic Myeloid Leukemia (CML) during Pregnancy Among Patients (pts) Treated with a Tyrosine Kinase Inhibitor (TKI): A Single-Center Experience

Characteristics of 809 Patients with Essential Thrombocythemia in Real-World Clinical Practice: A Chart Review Study in the United States

Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splanchnic or Cerebral Venous Thrombosis

SD-101, a Novel Class C CpG-Oligodeoxynucleotide (ODN) Toll-like Receptor 9 (TLR9) Agonist, Given with Low Dose Radiation for Untreated Low Grade B-Cell Lymphoma: Interim Results of a Phase 1/2 Trial

Maintenance Therapy for Patients with Mantle Cell Lymphoma (MCL) - a Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs)

Bridging to Second Allogeneic Peripheral Blood Stem Cell Transplantation with Nelarabine in a Patient with Multiply Relapsed/Refractory T-Cell ALL

The Effect of Initial Molecular Profile on Response to Recombinant Interferon Alpha (rIFNα) Treatment in Early Myelofibrosis

Hasford Score Is Correlated with 18 Month Molecular Response for Chronic Myeloid Leukemia Patients Treated with Second Generation Tyrosine Kinase Inhibitors and It May be Useful to Differentiate Low and Intermediate Risk Patients: A Single Institution Experience

Retrospective Analysis of Minimal Residual Disease-Guided Preemptive Treatment in Patients with AML and MDS - the SAL Study Group Experience

A Phase II Study of Panobinostat with Lenalidomide and Weekly Dexamethasone in Myeloma

Rituximab Maintenance (MR) for Patients with Mantle Cell Lymphoma (MCL) – a Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs)

Cladribine for the Management of Erdheim-Chester Histiocytosis in Adults

Pregnancy Management and Outcomes In Women With Myeloproliferative Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only